In patients with prediabetes, GLP‐1 RA initiation was associated with a lower risk of requiring additional glucose‐lowering therapy, compared with metformin; however, metformin initiation was associated with substantially higher levels of adherence. Here, GLP1R is linked to prediabetes syndrome.